Citadel Advisors
VMD icon

Citadel Advisors’s Viemed Healthcare VMD Stock Holding History

Citadel Advisors’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-200
Closed -$1.46K – 15286
2025
Q1 		$1.46K Hold
200
– – ﹤0.01% 14127
2024
Q4 		$1.6K Sell
200
-2,400
-92% -$20.8K ﹤0.01% 14168
2024
Q3 		$19.1K Sell
2,600
-1,100
-30% -$7.86K ﹤0.01% 12809
2024
Q2 		$24.2K Buy
+3,700
New +$27.9K ﹤0.01% 12469
2024
Q1 		– Sell
-700
Closed -$5.5K – 15496
2023
Q4 		$5.5K Buy
700
+600
+600% +$4.35K ﹤0.01% 13423
2023
Q3 		$673 Sell
100
-1,600
-94% -$13.1K ﹤0.01% 14005
2023
Q2 		$16.6K Buy
1,700
+700
+70% +$7.11K ﹤0.01% 12890
2023
Q1 		$9.66K Buy
+1,000
New +$8.72K ﹤0.01% 13578

Other funds holding VMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

Citadel Advisors's VMD Position: Q1 2026 in Review

Citadel Advisors reduced its Viemed Healthcare (VMD) stake by 81% in Q1 2026, selling an estimated $406K and leaving 11,730 shares worth $108K. The position accounts for ﹤0.01% of the portfolio, ranked #11941.

Citadel Advisors first reported a position in VMD in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.01M in Q2 2022. 149 funds tracked by Wall St. Rank hold VMD as of Q1 2026.

  • Citadel Advisors held 11,730 shares of Viemed Healthcare worth $108K as of Q1 2026.
  • Citadel Advisors sold 48,753 Viemed Healthcare shares in Q1 2026, an estimated $406K.
  • Viemed Healthcare made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #11941 holding.
  • Citadel Advisors first reported a position in Viemed Healthcare in Q3 2020 and has held it in 23 quarters since.
  • Citadel Advisors's Viemed Healthcare position peaked at $1.01M in Q2 2022.
  • 149 funds tracked by Wall St. Rank held Viemed Healthcare as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.